Royalty Pharma plc RPRX
Royalty Pharma plc is a leading company in the biopharmaceutical industry that specializes in acquiring and managing royalty interests in approved and development-stage therapies. The company's business model involves providing capital to biopharmaceutical innovators in exchange for a share of the future revenues generated by their products. It serves a wide range of partners, including large pharmaceutical companies, biotechnology firms, and academic research institutions, by funding research, development, and commercialization efforts. The company's portfolio consists of royalties from over 35 marketed products and several development-stage candidates across therapeutic areas such as rare diseases, oncology, neuroscience, and immunology. Royalty Pharma generates revenue primarily through royalty receipts from these products, supplemented by milestone payments and other contractual income, without engaging directly in drug discovery, development, or marketing.
LSTM Forecast
Forecast model is not trained yet for this market.
Train and backfill the LSTM forecast to surface a directional view here.